Transcenta-B Proposes Appointment of Xu Hansen as Non-Executive Director

Stock News06-04 19:24

The board of Transcenta Holding Limited - B (ASX: 06628) has announced a series of proposed changes to its composition and committee memberships.

It is recommended that Dr. Hansen Xu be appointed as a Non-Executive Director and that Dr. Jun Bao be appointed as an Independent Non-Executive Director. These appointments are subject to approval by the company's shareholders at the Annual General Meeting scheduled for June 30, 2026.

Concurrently, Dr. Kumar Srinivasan and Mr. Zhihua Zhang have tendered their resignations as Independent Non-Executive Directors to dedicate more time to other commitments. Their resignations will become effective upon the appointments of Dr. Xu and Dr. Bao.

Following their respective departures, Dr. Srinivasan will step down from his roles as Chairman of the Remuneration Committee and as a member of the Nomination Committee. Mr. Zhang will relinquish his positions as Chairman of the Nomination Committee, and as a member of both the Audit Committee and the Remuneration Committee.

Changes to the composition of the Audit, Remuneration, and Nomination Committees will also take effect once the new directors are appointed. Under the proposed changes, Dr. Jun Bao will join the Remuneration, Audit, and Nomination Committees. Ms. Wei Chen will be appointed as the Chairman of the Remuneration Committee. Dr. Hansen Xu will become a member of the Remuneration Committee, and Dr. Xueming Qian will be appointed as the Chairman of the Nomination Committee.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1173496112?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-04 19:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1173496112","market":"sh","top_or_hot":-1,"title":"Transcenta-B Proposes Appointment of Xu Hansen as Non-Executive Director","media":"Stock News","content":"<p>The board of <b>Transcenta Holding Limited - B</b> (<b>ASX: 06628</b>) has announced a series of proposed changes to its composition and committee memberships.<br><br>It is recommended that Dr. Hansen Xu be appointed as a Non-Executive Director and that Dr. Jun Bao be appointed as an Independent Non-Executive Director. These appointments are subject to approval by the company's shareholders at the Annual General Meeting scheduled for June 30, 2026.<br><br>Concurrently, Dr. Kumar Srinivasan and Mr. Zhihua Zhang have tendered their resignations as Independent Non-Executive Directors to dedicate more time to other commitments. Their resignations will become effective upon the appointments of Dr. Xu and Dr. Bao.<br><br>Following their respective departures, Dr. Srinivasan will step down from his roles as Chairman of the Remuneration Committee and as a member of the Nomination Committee. Mr. Zhang will relinquish his positions as Chairman of the Nomination Committee, and as a member of both the Audit Committee and the Remuneration Committee.<br><br>Changes to the composition of the Audit, Remuneration, and Nomination Committees will also take effect once the new directors are appointed. Under the proposed changes, Dr. Jun Bao will join the Remuneration, Audit, and Nomination Committees. Ms. Wei Chen will be appointed as the Chairman of the Remuneration Committee. Dr. Hansen Xu will become a member of the Remuneration Committee, and Dr. Xueming Qian will be appointed as the Chairman of the Nomination Committee.<br><br></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Transcenta-B Proposes Appointment of Xu Hansen as Non-Executive Director</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTranscenta-B Proposes Appointment of Xu Hansen as Non-Executive Director\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-06-04 19:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>The board of <b>Transcenta Holding Limited - B</b> (<b>ASX: 06628</b>) has announced a series of proposed changes to its composition and committee memberships.<br><br>It is recommended that Dr. Hansen Xu be appointed as a Non-Executive Director and that Dr. Jun Bao be appointed as an Independent Non-Executive Director. These appointments are subject to approval by the company's shareholders at the Annual General Meeting scheduled for June 30, 2026.<br><br>Concurrently, Dr. Kumar Srinivasan and Mr. Zhihua Zhang have tendered their resignations as Independent Non-Executive Directors to dedicate more time to other commitments. Their resignations will become effective upon the appointments of Dr. Xu and Dr. Bao.<br><br>Following their respective departures, Dr. Srinivasan will step down from his roles as Chairman of the Remuneration Committee and as a member of the Nomination Committee. Mr. Zhang will relinquish his positions as Chairman of the Nomination Committee, and as a member of both the Audit Committee and the Remuneration Committee.<br><br>Changes to the composition of the Audit, Remuneration, and Nomination Committees will also take effect once the new directors are appointed. Under the proposed changes, Dr. Jun Bao will join the Remuneration, Audit, and Nomination Committees. Ms. Wei Chen will be appointed as the Chairman of the Remuneration Committee. Dr. Hansen Xu will become a member of the Remuneration Committee, and Dr. Xueming Qian will be appointed as the Chairman of the Nomination Committee.<br><br></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09939","symbol_name":"开拓药业-B","start_time":0,"source_url":"","article_id":"1173496112","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1173496112","pubTimestamp":1780572274,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"The board of Transcenta Holding Limited - B (ASX: 06628) has announced a series of proposed changes to its composition and committee memberships.It is recommended that Dr. Hansen Xu be appointed as a...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159938":"医药","09939":"开拓药业-B","BK1515":"抗疫概念","BK1574":"生物医药B类股","BK1161":"生物科技","06628":"创胜集团医药-B"},"translate_title":"Transcenta-B建议委任徐汉森为非执行董事","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159938":1,"09939":1,"06628":1},"content_text":"The board of Transcenta Holding Limited - B (ASX: 06628) has announced a series of proposed changes to its composition and committee memberships.It is recommended that Dr. Hansen Xu be appointed as a Non-Executive Director and that Dr. Jun Bao be appointed as an Independent Non-Executive Director. These appointments are subject to approval by the company's shareholders at the Annual General Meeting scheduled for June 30, 2026.Concurrently, Dr. Kumar Srinivasan and Mr. Zhihua Zhang have tendered their resignations as Independent Non-Executive Directors to dedicate more time to other commitments. Their resignations will become effective upon the appointments of Dr. Xu and Dr. Bao.Following their respective departures, Dr. Srinivasan will step down from his roles as Chairman of the Remuneration Committee and as a member of the Nomination Committee. Mr. Zhang will relinquish his positions as Chairman of the Nomination Committee, and as a member of both the Audit Committee and the Remuneration Committee.Changes to the composition of the Audit, Remuneration, and Nomination Committees will also take effect once the new directors are appointed. Under the proposed changes, Dr. Jun Bao will join the Remuneration, Audit, and Nomination Committees. Ms. Wei Chen will be appointed as the Chairman of the Remuneration Committee. Dr. Hansen Xu will become a member of the Remuneration Committee, and Dr. Xueming Qian will be appointed as the Chairman of the Nomination Committee.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1173496112","isCrawlerRequest":true}